The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
Abstract Human papillomavirus (HPV) infection is the main cause of female precancerous lesions and cervical cancer. The development and application of HPV prophylactic vaccines have been recognized as a major effective intervention for the control of cervical lesions. However, the infection rate and...
Main Authors: | Mingjun Ma, Jingfen Zhu, Yongbin Yang, Xiaoyun Wang, Yubiao Jin, Jiawen Zhang, Sufang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4532 |
Similar Items
-
Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect
by: Ling Han, et al.
Published: (2023-10-01) -
The specific features of cervical intraepithelial neoplasia associated with persistent HPV infection
by: Tatiana V Klinyshkova, et al.
Published: (2019-06-01) -
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT
by: Clare Gilham, et al.
Published: (2019-06-01) -
Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01) -
Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women
by: Vidal Adriana C, et al.
Published: (2011-11-01)